Literature DB >> 9207940

Conformationally restrained melatonin analogues: synthesis, binding affinity for the melatonin receptor, evaluation of the biological activity, and molecular modeling study.

G Spadoni1, C Balsamini, G Diamantini, B Di Giacomo, G Tarzia, M Mor, P V Plazzi, S Rivara, V Lucini, R Nonno, M Pannacci, F Fraschini, B M Stankov.   

Abstract

The design, synthesis, and biological profile of several indole melatonin analogues with a conformationally restricted C3 amidoethane side chain are presented. Examination of the accessible conformations of the melatonin side chain led us to explore some of its fully or partially restricted analogues, 2-12, the binding affinity values of which were utilized to gain further insight on the melatonin binding site. Two pharmacophoric models have been devised for melatonin and the active compounds by conformational analysis and superimposition performed using the DISCO program. In these models, the melatonin side chain can adopt a gauche/anti conformation out of the indole plane. Another contribution of this study regards the observation of a possible binding point interaction around the C2 position of the indole, as suggested by the remarkably increased binding affinity observed in the C2-substituted analogues 6 and 9 and especially in the more rigid analogue 5. The biological activity and the efficacy of the new compounds were tested by measuring the inhibition of the forskolin-stimulated cAMP accumulation and the GTP gamma S index. Both analyses demonstrated that all of the compounds were full agonists with the exception of 4 and 9, which showed a slight reduction in efficacy and would seem to be partial agonists.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9207940     DOI: 10.1021/jm960651z

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

2.  The marine natural-derived inhibitors of glycogen synthase kinase-3beta phenylmethylene hydantoins: In vitro and in vivo activities and pharmacophore modeling.

Authors:  Mohammad A Khanfar; Bilal Abu Asal; Mudit Mudit; Amal Kaddoumi; Khalid A El Sayed
Journal:  Bioorg Med Chem       Date:  2009-06-27       Impact factor: 3.641

3.  Investigation on quantitative structure activity relationships and pharmacophore modeling of a series of mGluR2 antagonists.

Authors:  Meng-Qi Zhang; Xiao-Le Zhang; Yan Li; Wen-Jia Fan; Yong-Hua Wang; Ming Hao; Shu-Wei Zhang; Chun-Zhi Ai
Journal:  Int J Mol Sci       Date:  2011-09-16       Impact factor: 5.923

4.  New quinoxaline derivatives as potential MT₁ and MT₂ receptor ligands.

Authors:  Saioa Ancizu; Nerea Castrillo; Silvia Pérez-Silanes; Ignacio Aldana; Antonio Monge; Philippe Delagrange; Daniel-Henry Caignard; Silvia Galiano
Journal:  Molecules       Date:  2012-06-25       Impact factor: 4.411

Review 5.  Cardioprotective Melatonin: Translating from Proof-of-Concept Studies to Therapeutic Use.

Authors:  Ovidiu Constantin Baltatu; Sergio Senar; Luciana Aparecida Campos; José Cipolla-Neto
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.